Have questions about IVF and infertility? We have answers.
Update #1 Released to the ASRM Patient Management and Clinical Recommendations During The Coronavirus (COVID-19) Pandemic
Mar 30, 2020
Published in: ASRM Announcement
The ASRM Task Force continues to be committed to a return to routine patient care as soon as possible. However, it is unclear how long the COVID-19 pandemic will continue. Epidemiologic evidence suggests that the speed by which it lessens is proportional to the degree of adherence to CDC guidance, including strictly following hygiene recommendations, shelter-at-home, and rigorous social distancing.
At this time, the ASRM Coronavirus/COVID-19 Task Force affirms all of the stated recommendations of March 17, 2020 as timely and appropriate, including:
- Suspend initiation of new treatment cycles, including ovulation induction, intrauterine inseminations (IUIs), in vitro fertilization (IVF) including retrievals and frozen embryo transfers, as well as non-urgent gamete cryopreservation.
- Strongly consider cancellation of all embryo transfers whether fresh or frozen.
- Continue to care for patients who are currently “in-cycle” or who require urgent stimulation and cryopreservation.
- Suspend elective surgeries and non-urgent diagnostic procedures.
- Minimize in-person interactions and increase utilization of telehealth.
our broader communities. This update reflects the stated commitment of the Task force to reassess its recommendations at no more than two-week intervals considering the fluid and evolving situation.
Read the Full Text Recommendations:
- Update #1 - published March 30, 2020
- Patient Management and Clinical Recommendations During The Coronavirus (COVID-19) Pandemic - published March 17, 2020